| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.24 | 0.4 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.4 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.5 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |